The latest report by IMARC Group, titled “Immunoassay Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the immunoassay industry report. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global immunoassay market size reached US$ 31.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Immunoassay Market Trends:
The global immunoassay market is being driven by the increasing prevalence of chronic and infectious diseases, necessitating advanced diagnostic solutions for early detection and monitoring. Immunoassays, known for their high sensitivity and specificity, are widely adopted in clinical laboratories for diagnosing conditions such as cancer, cardiovascular diseases, and autoimmune disorders. Along with this, the rising demand for personalized medicine and targeted therapies is also contributing to the market's growth, as immunoassays play a crucial role in identifying biomarkers and guiding treatment decisions.
Additionally, the growing emphasis on preventive healthcare and routine screening is driving the adoption of immunoassay-based tests. Technological advancements, including the development of automated immunoassay platforms and multiplex assays, are further enhancing the efficiency and throughput of diagnostic procedures, making them more accessible to healthcare providers. Furthermore, government initiatives to improve healthcare infrastructure and increase access to diagnostic services, particularly in emerging markets, are positively influencing the market's expansion.
Request to Get the Sample Report: https://www.imarcgroup.com/immunoassay-market/requestsample
Immunoassay Market Scope and Growth Analysis:
The scope of the market is expanding as the technology is increasingly integrated into various healthcare applications beyond diagnostics, including drug development, therapeutic monitoring, and environmental testing. The market is experiencing robust growth due to the rising adoption of immunoassays in research and academic institutions, where they are used to study disease mechanisms and identify potential therapeutic targets. The demand for point-of-care testing (POCT) is also driving market growth, with immunoassay-based rapid tests becoming essential tools in emergency and outpatient settings.
Furthermore, the increasing use of immunoassays in food safety testing, to detect allergens and contaminants, is broadening the market's application areas. The market is also benefiting from the trend toward laboratory automation, where advanced immunoassay analyzers are integrated with laboratory information management systems (LIMS) to enhance workflow efficiency and data accuracy. As per market analysis, the focus on innovation and expanding applications is a key factor in broadening the market scope.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/immunoassay-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott
- Becton Dickinson and Company
- BioMérieux SA
- Danaher Corporation
- Merck KGaA
- PerkinElmer Inc
- Quidel Corporation
- Siemens Healthcare Pty Ltd (Siemens AG)
- Sysmex Corporation
- Thermo Fisher Scientific
Immunoassay Market Segmentation:
Our report has categorized the market based on region, technology, product, application and end use.
Breakup by Technology:
- Radioimmunoassay
- Enzyme Immunoassay
- Rapid Test
- Others
Breakup by Product:
- Reagents and Kits
- Analyzers/Instruments
- Software and Services
Breakup by Application:
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
Breakup by End Use:
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
